Randomized Controlled Trials With Time-to-Event Outcomes: How Much Does Prespecified Covariate Adjustment Increase Power?
Authors:
- Adrián V. HernándezAHAdrián V. Hernández
- Marinus J.C. EijkemansMEMarinus J.C. Eijkemans
- Ewout W. SteyerbergESEwout W. Steyerberg
- 1 January 2006
- journal article
- Published by Elsevier in Annals of Epidemiology
- Vol. 16 (1) , 41-48
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- The role of covariates in estimating treatment effects and risk in long‐term clinical trialsStatistics in Medicine, 2002
- Clinical trials in the new millenniumStatistics in Medicine, 2002
- Covariate adjustment for non‐parametric tests for censored survival dataStatistics in Medicine, 2001
- Survival Analysis in Clinical Trials: Past Developments and Future DirectionsBiometrics, 2000
- Should We Adjust for Covariates in Nonlinear Regression Analyses of Randomized Trials?Controlled Clinical Trials, 1998
- POWER OF LOGRANK TEST AND COX REGRESSION MODEL IN CLINICAL TRIALS WITH HETEROGENEOUS SAMPLESStatistics in Medicine, 1997
- EFFECTS OF COVARIATE OMISSION AND CATEGORIZATION WHEN ANALYSING RANDOMIZED TRIALS WITH THE COX MODELStatistics in Medicine, 1997
- Model inconsistency, illustrated by the cox proportional hazards modelStatistics in Medicine, 1995
- The impact of heterogeneity on the comparison of survival timesStatistics in Medicine, 1987
- Biased estimates of treatment effect in randomized experiments with nonlinear regressions and omitted covariatesBiometrika, 1984